Duggan Robert W

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Duggan Robert W
CRD #170471
SEC #801-80082
CIK #0001055919
AUM
Employees 1 (100% Investors, 0% Brokers)
Fees
Minimum
Phone503-720-3175
Address1740 Gulf Blvd
Belleair Beach, FL 33786
Source [IAPD] [EDGAR]
Total AUM ($B)
3.02.41.81.20.60.02009201420192025
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 0 0.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 48 3.0
By Discretionary
Discretionary 15 2.9
Non-Discretionary 33 0.1
Total 48 3.0
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 3.0
Total 48 3.0
EDGAR Form CIK 2011 - 2026
3 [0001055919]
4 [0001055919]
5 [0001055919]
SC 13D [0001055919]
Form 13D/13G Filer Form 13D/13G Subject Filed
Duggan Robert W Summit Therapeutics Inc [2020-09-28]
Duggan Robert W Summit Therapeutics PLC [2019-01-22]
Duggan Robert W Aurinia Pharmaceuticals Inc [2017-05-01]
Duggan Robert W Achaogen Inc [2017-03-28]
Duggan Robert W Pulse Biosciences Inc [2017-02-21]
Firm Profile (Form ADV)
Discretionary AUM$2.9B
ServesInstitutional, Retail
Form 3/4/5 Subject 2011 - 2026
Duggan Robert W
Pulse Biosciences Inc
Summit Therapeutics Inc
Achaogen Inc
Pharmacyclics Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
2026-01-02 Grant 11,232 $8.76 98,392
Summit Therapeutics Inc SMMT
Common Stock
2025-10-21 Grant 266,808 $18.74 4,999,982
Summit Therapeutics Inc SMMT
Common Stock
2025-10-21 Grant 13,980,789 $18.74 261,999,986
Summit Therapeutics Inc SMMT
Common Stock
2025-10-21 Buy 26,680 $18.74 499,983
Pulse Biosciences Inc PLSE
Stock Option (right to buy) · derivative
2025-08-15 Grant 30,000 $0.00
Pulse Biosciences Inc PLSE
Stock Option (right to buy) · derivative
2025-08-15 Grant 20,792 $0.00
Summit Therapeutics Inc SMMT
Common Stock
2025-05-30 Option exercise 74,545 $2.64 196,799
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
2025-05-30 Option exercise 74,545 $0.00
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
2025-04-29 Grant 400,000
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
2025-04-29 Grant 9,590,558
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
2025-04-29 Grant 1,040,000
Summit Therapeutics Inc SMMT
Common Stock
2025-04-08 Option exercise 3,985,055 $1.58 6,296,387
Summit Therapeutics Inc SMMT
Warrant (right to buy) · derivative
2025-04-08 Option exercise 3,985,055 $0.00
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
2025-01-02 Grant 10,724 $9.18 98,446
Pulse Biosciences Inc PLSE
Common Stock
2024-12-18 Option exercise 5,187,824 $11.00 57,066,064
Pulse Biosciences Inc PLSE
Common Stock
2024-12-18 Option exercise 69,020 $11.00 759,220
Pulse Biosciences Inc PLSE
Common Stock
2024-12-18 Option exercise 49,312 $11.00 542,432
Pulse Biosciences Inc PLSE
Warrants (right to buy) · derivative
2024-12-18 Option exercise 34,510
Pulse Biosciences Inc PLSE
Warrants (right to buy) · derivative
2024-12-18 Option exercise 34,510
Pulse Biosciences Inc PLSE
Warrants (right to buy) · derivative
2024-12-18 Option exercise 24,656
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com